BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 33029089)

  • 1. Association of procalcitonin levels with the progression and prognosis of hospitalized patients with COVID-19.
    Liu ZM; Li JP; Wang SP; Chen DY; Zeng W; Chen SC; Huang YH; Huang JL; Long W; Li M; Gao RF; Guo L; Wu XH
    Int J Med Sci; 2020; 17(16):2468-2476. PubMed ID: 33029089
    [No Abstract]   [Full Text] [Related]  

  • 2. Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study.
    Pan F; Yang L; Li Y; Liang B; Li L; Ye T; Li L; Liu D; Gui S; Hu Y; Zheng C
    Int J Med Sci; 2020; 17(9):1281-1292. PubMed ID: 32547323
    [No Abstract]   [Full Text] [Related]  

  • 3. Associations of procalcitonin, C-reaction protein and neutrophil-to-lymphocyte ratio with mortality in hospitalized COVID-19 patients in China.
    Xu JB; Xu C; Zhang RB; Wu M; Pan CK; Li XJ; Wang Q; Zeng FF; Zhu S
    Sci Rep; 2020 Sep; 10(1):15058. PubMed ID: 32929124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of overweight in COVID-19: A retrospective analysis in a single center of Wuhan, China.
    Rao X; Wu C; Wang S; Tong S; Wang G; Wu G; Zhou R
    Medicine (Baltimore); 2020 Oct; 99(43):e22766. PubMed ID: 33120785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired immune and coagulation systems may be early risk factors for COVID-19 patients: A retrospective study of 118 inpatients from Wuhan, China.
    Qin ZJ; Liu L; Sun Q; Li X; Luo JF; Liu JS; Liu D
    Medicine (Baltimore); 2020 Aug; 99(35):e21700. PubMed ID: 32871887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of China.
    Liang WH; Guan WJ; Li CC; Li YM; Liang HR; Zhao Y; Liu XQ; Sang L; Chen RC; Tang CL; Wang T; Wang W; He QH; Chen ZS; Wong SS; Zanin M; Liu J; Xu X; Huang J; Li JF; Ou LM; Cheng B; Xiong S; Xie ZH; Ni ZY; Hu Y; Liu L; Shan H; Lei CL; Peng YX; Wei L; Liu Y; Hu YH; Peng P; Wang JM; Liu JY; Chen Z; Li G; Zheng ZJ; Qiu SQ; Luo J; Ye CJ; Zhu SY; Cheng LL; Ye F; Li SY; Zheng JP; Zhang NF; Zhong NS; He JX
    Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32269086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT Quantitative Analysis and Its Relationship with Clinical Features for Assessing the Severity of Patients with COVID-19.
    Sun D; Li X; Guo D; Wu L; Chen T; Fang Z; Chen L; Zeng W; Yang R
    Korean J Radiol; 2020 Jul; 21(7):859-868. PubMed ID: 32524786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study.
    Xu PP; Tian RH; Luo S; Zu ZY; Fan B; Wang XM; Xu K; Wang JT; Zhu J; Shi JC; Chen F; Wan B; Yan ZH; Wang RP; Chen W; Fan WH; Zhang C; Lu MJ; Sun ZY; Zhou CS; Zhang LN; Xia F; Qi L; Zhang W; Zhong J; Liu XX; Zhang QR; Lu GM; Zhang LJ
    Theranostics; 2020; 10(14):6372-6383. PubMed ID: 32483458
    [No Abstract]   [Full Text] [Related]  

  • 9. Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort.
    Cheng B; Hu J; Zuo X; Chen J; Li X; Chen Y; Yang G; Shi X; Deng A
    Clin Microbiol Infect; 2020 Oct; 26(10):1400-1405. PubMed ID: 32622952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of lactate dehydrogenase for in-hospital mortality in severe and critically ill patients with COVID-19.
    Dong X; Sun L; Li Y
    Int J Med Sci; 2020; 17(14):2225-2231. PubMed ID: 32922185
    [No Abstract]   [Full Text] [Related]  

  • 11. Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China.
    Chen R; Liang W; Jiang M; Guan W; Zhan C; Wang T; Tang C; Sang L; Liu J; Ni Z; Hu Y; Liu L; Shan H; Lei C; Peng Y; Wei L; Liu Y; Hu Y; Peng P; Wang J; Liu J; Chen Z; Li G; Zheng Z; Qiu S; Luo J; Ye C; Zhu S; Liu X; Cheng L; Ye F; Zheng J; Zhang N; Li Y; He J; Li S; Zhong N;
    Chest; 2020 Jul; 158(1):97-105. PubMed ID: 32304772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.
    Wang Y; Zhou Y; Yang Z; Xia D; Hu Y; Geng S
    Respiration; 2020; 99(8):649-657. PubMed ID: 32841948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse Initial CT Findings Associated with Poor Prognosis of Coronavirus Disease.
    Chon Y; Kim JY; Suh YJ; Lee JY; Park JS; Moon SM; Lee MS; Yi J
    J Korean Med Sci; 2020 Aug; 35(34):e316. PubMed ID: 32864912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factors for Poor Outcomes of Diabetes Patients With COVID-19: A Single-Center, Retrospective Study in Early Outbreak in China.
    Zhang N; Wang C; Zhu F; Mao H; Bai P; Chen LL; Zeng T; Peng MM; Qiu KL; Wang Y; Yu M; Xu S; Zhao J; Li N; Zhou M
    Front Endocrinol (Lausanne); 2020; 11():571037. PubMed ID: 33071977
    [No Abstract]   [Full Text] [Related]  

  • 15. Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study.
    Wu J; Huang J; Zhu G; Wang Q; Lv Q; Huang Y; Yu Y; Si X; Yi H; Wang C; Liu Y; Xiao H; Zhou Q; Liu X; Yang D; Guan X; Li Y; Peng S; Sung J; Xiao H
    BMJ Open Diabetes Res Care; 2020 Jun; 8(1):. PubMed ID: 32503812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated α-hydroxybutyrate dehydrogenase as an independent prognostic factor for mortality in hospitalized patients with COVID-19.
    Liu Z; Li J; Li M; Chen S; Gao R; Zeng G; Chen D; Wang S; Li Q; Hu D; Zeng W; Guo L; Wu X
    ESC Heart Fail; 2021 Feb; 8(1):644-651. PubMed ID: 33336560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of clinical and radiographic findings with the outcomes of 93 patients with COVID-19 in Wuhan, China.
    Li L; Yang L; Gui S; Pan F; Ye T; Liang B; Hu Y; Zheng C
    Theranostics; 2020; 10(14):6113-6121. PubMed ID: 32483442
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibiotic stewardship: Early discontinuation of antibiotics based on procalcitonin level in COVID-19 pneumonia.
    Roy A; Powers HR; Craver EC; Nazareno MD; Yarrarapu SNS; Sanghavi DK
    J Clin Pharm Ther; 2022 Feb; 47(2):243-247. PubMed ID: 34766357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of procalcitonin in cancer patients with coronavirus disease 2019.
    Tiutan T; Wallins JS; Brown S; Gonen M; Korenstein D
    Clin Chem Lab Med; 2023 Jan; 61(2):339-348. PubMed ID: 36367353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Features of COVID-19 Patients with Different Outcomes in Wuhan: A Retrospective Observational Study.
    Wang Z; Ye D; Wang M; Zhao M; Li D; Ye J; Liu J; Xu Y; Zhang J; Pan W; Liu M; Luo Z; Wan J
    Biomed Res Int; 2020; 2020():2138387. PubMed ID: 33029494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.